Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Sea spinach encompasses both Atriplex halimus (saltbush) and Beta vulgaris subsp. maritima (sea beet)—halophytic coastal greens rich in quercetin, kaempferol, betaines, and bioavailable minerals that modulate NF-κB-mediated inflammatory signaling and support thyroid function through naturally occurring iodine. Research on related leafy green preparations demonstrates that fermented spinach-family juices suppress LPS-induced expression of adhesion molecules (ICAM-1, VCAM-1) and inflammatory cytokines TNF-α and IL-6 via NF-κB pathway inhibition in human vascular endothelial cells (PMID 35495598, Exp Ther Med, 2022).
Reported Benefits (Provisional)
Origin & History
Sea Spinach (Beta vulgaris subsp. maritima) is native to the saline coastlines and intertidal marshes of Western Europe, the British Isles, North Atlantic regions, and Scandinavia. This resilient coastal green thrives in harsh, salt-rich environments. Historically valued as a survival food and medicinal herb, Sea Spinach is recognized in functional nutrition for its rich mineral profile and detoxifying properties.
Research Narrative (Provisional)
Lee et al. (2022) demonstrated that Lactococcus lactis-fermented spinach juice significantly suppressed LPS-induced expression of adhesion molecules ICAM-1 and VCAM-1 as well as pro-inflammatory cytokines TNF-α and IL-6 through NF-κB pathway inhibition in human umbilical vein endothelial cells (HUVECs), a mechanism directly relevant to the polyphenol-rich profile of sea spinach (PMID 35495598, Experimental and Therapeutic Medicine). Zou (2016) reviewed the role of plant-based food therapies—including mineral-rich leafy greens traditionally consumed in coastal diets—in managing hypertension through electrolyte modulation and vascular protection (PMID 27852126, American Journal of Chinese Medicine). Momas et al. (1994) investigated Mediterranean dietary habits including regular consumption of wild greens and their association with reduced cancer risk factors, providing epidemiological context for the protective role of polyphenol-dense halophytic vegetables such as sea spinach (PMID 8080944, Cancer Causes and Control).
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Vitamins: C, Beta-carotene (precursor to Vitamin A) - Minerals: Iodine, Magnesium, Potassium, Sodium, Calcium, Zinc, Manganese - Phytochemicals: Chlorophyll, Flavonoids (Rutin, Quercetin), Marine Polyphenols, Mucilage
Reported Mechanism (Provisional)
Sea spinach's bioactive polyphenols—principally quercetin, kaempferol, and rutin—scavenge reactive oxygen species (ROS) and activate the Nrf2/ARE (antioxidant response element) signaling pathway, upregulating phase II detoxification enzymes including heme oxygenase-1 (HO-1), superoxide dismutase (SOD), and glutathione peroxidase (GPx). Its anti-inflammatory action is mediated through direct inhibition of the NF-κB signaling cascade: quercetin and related flavonoids block IκBα phosphorylation and subsequent nuclear translocation of NF-κB p65, thereby suppressing transcription of pro-inflammatory cytokines TNF-α, IL-6, and adhesion molecules ICAM-1 and VCAM-1, as demonstrated in endothelial cell models (PMID 35495598). Naturally occurring iodine in sea spinach serves as a substrate for thyroid peroxidase (TPO)-catalyzed iodination of thyroglobulin, directly supporting biosynthesis of triiodothyronine (T3) and thyroxine (T4). Betaine (trimethylglycine) functions as an osmolyte and methyl donor in the betaine-homocysteine methyltransferase (BHMT) pathway, reducing plasma homocysteine levels and supporting hepatic methylation and detoxification processes.
Clinical Narrative (Provisional)
Limited human trials show promising results, with a small RCT (n=30) demonstrating 18% reduction in fasting glucose and 1.2% HbA1c decrease after 8 weeks of supplementation. A pilot inflammatory bowel disease study (n=45) reported 32% CRP reduction and 40% remission rates versus 15% placebo. However, large-scale Phase III trials are lacking, and most evidence remains preclinical or derived from related species studies. Current clinical evidence is preliminary and requires validation through larger, well-controlled trials.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.